Bank of New York Mellon Corp
BankPosition in ELAN — Elanco Animal Health Inc
CIK 1390777
NEW YORK, NY
Position in ELAN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$91,170,611
+$2,578,380 QoQ
Shares Held
3,809,888
-2.7% QoQ
Ownership
0.763%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 92.56104116446467.ToString("F0")%
Shared 0.ToString("F0")%
None 7.438958835535322.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $1,371,862,681 across 46 Drug Manufacturers - Specialty & Generic names. ELAN ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,899,720 | $460,985,889 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
329,148 | $195,178,172 | |
| 3 | VTRS |
Viatris Inc
|
14,128,917 | $190,881,662 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
702,492 | $92,546,288 | |
| 5 | ELAN |
Elanco Animal Health Inc
This page
|
3,809,888 | $91,170,611 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,794,432 | $54,048,287 | |
| 7 | ALKS |
Alkermes plc.
|
1,036,460 | $36,649,221 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
463,751 | $35,175,507 |
All Filings in ELAN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $91,170,611 | 3,809,888 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $88,592,231 | 3,914,814 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $103,340,671 | 5,131,116 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $25,293,502 | 1,771,254 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $20,578,778 | 1,959,884 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $24,312,382 | 2,007,629 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $30,513,080 | 2,077,133 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $33,043,483 | 2,289,916 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $36,995,157 | 2,272,430 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $33,485,570 | 2,247,354 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $20,782,014 | 1,848,934 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $17,350,568 | 1,724,709 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $18,465,271 | 1,964,391 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $24,633,231 | 2,015,813 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $36,205,624 | 2,917,456 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $59,052,609 | 3,008,284 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $162,638,636 | 6,233,754 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $168,268,672 | 5,929,129 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $201,276,438 | 6,311,585 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $137,974,785 | 3,977,365 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $117,996,929 | 4,006,687 | Shares | Other | 2021-05-13 | |
| 2020-09-30 | $44,273,235 | 1,585,150 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $31,495,911 | 1,468,341 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $31,806,379 | 1,420,562 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||